Elicio Therapeutics ELTX
NASDAQ ELTX
$1.94 +0.27 (+16.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Elicio Therapeutics (ELTX) posted Return on Capital Employed [ROCE] of -212.93% for Q2 2026, up 23.13 percentage points from -236.07% a year earlier and up 7.52 percentage points from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Elicio Therapeutics' Return on Capital Employed [ROCE] came in at -199.44%, up 79.30 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of -134.61 percentage points (FY2021 to FY2025).
  • In prior years, Elicio Therapeutics' Return on Capital Employed [ROCE] was -278.74% in FY2024 (-42.80 pp), -235.94% in FY2023 (-190.92 pp), -45.02% in FY2022 (+19.81 pp) and -64.83% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -329.83% in Q2 2024 to a high of -20.48% in Q3 2022 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last five quarters, with an average year-over-year change of +3.42 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2025, with a gain of 93.77 percentage points; the weakest was Q2 2024, with a drop of 244.73 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -220.46% (Q1 2026), -198.88% (Q4 2025) and -189.13% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 Elicio Therapeutics 42.49 Mn -35.13 Mn - -212.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -212.93%
Mar 31, 2026 -220.46%
Dec 31, 2025 -198.88%
Sep 30, 2025 -189.13%
Jun 30, 2025 -236.07%
Mar 31, 2025 -271.55%
Dec 31, 2024 -206.73%
Sep 30, 2024 -226.61%
Jun 30, 2024 -329.83%
Mar 31, 2024 -192.23%
Dec 31, 2023 -185.10%
Sep 30, 2023 -141.62%
Jun 30, 2023 -85.10%
Mar 31, 2023 -85.37%
Dec 31, 2022 -92.39%
Sep 30, 2022 -20.48%
Jun 30, 2022 -32.00%
Mar 31, 2022 -43.12%
Dec 31, 2021 -42.76%
Sep 30, 2021 -67.99%
API Access

Elicio Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ELTX&period=max&api_key=YOUR_API_KEY